Skip to main content

Table 3 Pooled prevalence of radiological findings and treatment of pregnant women with coronavirus infection in the present systematic review and meta–analysis

From: The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal–fetal transmission: a systematic review and meta-analysis

Radiological finding and treatment of patients with CoV infection Study (n) Number of reports Pregnancies (n) Pooled % (95%-CI)
Radiological finding
 Unilateral pneumonia 2 3 15 20% [4.4–48.6]
 Bilateral pneumonia 6 11 19 57.9% [33.5–80.1]
 Ground-glass opacity 8 50 76 65.8% [54.2–76.4]
 Multiple patchy infiltrate 5 5 22 22.7% [8.9–45.2]
Treatment
 Oseltamivir 6 14 23 56.5% [35.1–64.3]
 Remdesivir 5 3 16 18.8% [13.8–29.1]
 Lopinavir 2 2 12 16.7% [13.1–41.1]
 Ritonavir 3 2 13 15.4% [10.1–31.7]
 Ganciclovir 7 2 10 20% [12.8–44.2]
 Ribavirin 11 15 23 65.2% [47.3–78.4]
 Other antiviral therapy 11 89 128 69.5% [39.2–77.8]
 Azithromycin 4 7 20 35% [22.3–48.5]
 Other antibiotic therapy 13 102 157 64.9% [60.9–73.1]
 Hydroxychloroquine 12 59 74 79.7% [70.1–89.3]
 Hydrocortisone 3 11 24 45.8% [37.2–59.6]
 Mechanical ventilation 7 23 127 18.1% [12.26.8]
 Oxygen therapy 9 89 113 78.8% [65.4–89.6]
\